Royal Bank of Canada
IDYA icon

Royal Bank of Canada’s IDEAYA Biosciences IDYA Stock Holding History

Royal Bank of Canada’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.89M Sell
158,152
-3,685
-2% -$113K ﹤0.01% 2485
2026
Q1 		$5.39M Sell
161,837
-3,486
-2% -$117K ﹤0.01% 2364
2025
Q4 		$5.71M Sell
165,323
-244,296
-60% -$7.79M ﹤0.01% 2315
2025
Q3 		$11.1M Buy
409,619
+31,847
+8% +$770K ﹤0.01% 2077
2025
Q2 		$7.94M Buy
377,772
+255,312
+208% +$4.9M ﹤0.01% 2203
2025
Q1 		$2.01M Buy
122,460
+28,322
+30% +$603K ﹤0.01% 2945
2024
Q4 		$2.42M Buy
94,138
+12,159
+15% +$344K ﹤0.01% 2897
2024
Q3 		$2.6M Sell
81,979
-8,503
-9% -$322K ﹤0.01% 2794
2024
Q2 		$3.18M Buy
90,482
+36,758
+68% +$1.46M ﹤0.01% 2544
2024
Q1 		$2.36M Buy
53,724
+35,332
+192% +$1.52M ﹤0.01% 2795
2023
Q4 		$654K Buy
18,392
+10,557
+135% +$315K ﹤0.01% 4031
2023
Q3 		$211K Buy
7,835
+3,429
+78% +$87K ﹤0.01% 4755
2023
Q2 		$103K Sell
4,406
-22,826
-84% -$469K ﹤0.01% 5316
2023
Q1 		$373K Buy
27,232
+395
+1% +$6.58K ﹤0.01% 4118
2022
Q4 		$487K Buy
26,837
+26,385
+5,837% +$444K ﹤0.01% 4133
2022
Q3 		$6K Sell
452
-168
-27% -$2.18K ﹤0.01% 6663
2022
Q2 		$9K Sell
620
-1,413
-70% -$15.7K ﹤0.01% 6424
2022
Q1 		$23K Sell
2,033
-4,575
-69% -$67.4K ﹤0.01% 6532
2021
Q4 		$156K Buy
6,608
+3,084
+88% +$71.6K ﹤0.01% 5584
2021
Q3 		$90K Buy
3,524
+1,595
+83% +$37.2K ﹤0.01% 5779
2021
Q2 		$40K Buy
1,929
+235
+14% +$4.83K ﹤0.01% 6184
2021
Q1 		$40K Buy
1,694
+630
+59% +$12.2K ﹤0.01% 6020
2020
Q4 		$15K Buy
1,064
+1,040
+4,333% +$14.1K ﹤0.01% 6194
2020
Q3 		$0 Buy
+24
New +$297 ﹤0.01% 6756

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Royal Bank of Canada's IDYA Position: Q2 2026 in Review

Royal Bank of Canada reduced its IDEAYA Biosciences (IDYA) stake by 2.3% in Q2 2026, selling an estimated $113K and leaving 158,152 shares worth $5.89M. The position accounts for ﹤0.01% of the portfolio, ranked #2485.

Royal Bank of Canada first reported a position in IDYA in Q3 2020 and has held it in 24 quarters since. The position peaked at $11.1M in Q3 2025. 282 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Royal Bank of Canada held 158,152 shares of IDEAYA Biosciences worth $5.89M as of Q2 2026.
  • Royal Bank of Canada sold 3,685 IDEAYA Biosciences shares in Q2 2026, an estimated $113K.
  • IDEAYA Biosciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #2485 holding.
  • Royal Bank of Canada first reported a position in IDEAYA Biosciences in Q3 2020 and has held it in 24 quarters since.
  • Royal Bank of Canada's IDEAYA Biosciences position peaked at $11.1M in Q3 2025.
  • 282 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.